Mapping of clinical trials
The active trial map is organised according to broad histological type and specific segmentation criteria. The planned number of patients and the beginning and (theoretical) end date of recruitment are shown for each trial.
In particular, this makes it possible:
- for the centres to more easily visualise the trials that can be offered to patients
- to give the various stakeholders an overview of LYSA trials
- to identify the types of patients for whom there are currently no trials
- to work out the schedule for the future protocols that are to be set up